Roy Galvin serves as Executive at HAEMONETICS CORP, where they oversee executive responsibilities. Since joining the company, Roy Galvin has executed 6 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Oct 31, 2025 involved selling 145 shares valued at $7.3K.
Roy Galvin currently holds 12,811 shares of HAEMONETICS CORP (HAE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Roy Galvin has been a net neutral trader of HAE stock. They have purchased $0 and sold $0 worth of shares.
Roy Galvin's most recent insider trade was on Oct 31, 2025, when they sold 145 shares at $50.01 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| May 15, 2024 | HAE | $20.6K | Payment | 214 | $96.49 | Discretionary |
| Nov 1, 2023 | HAE | $13.8K | Payment | 160 | $86.39 | Discretionary |
| May 15, 2023 | HAE | $0 | Award | 2,243 | $N/A | Discretionary |
| Nov 1, 2022 | HAE | $0 | Award | 2,382 | $N/A | Discretionary |